Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Yes-associated Protein: Early Diagnosis Of Gastric Carcinoma
ScienceDaily, 09/17/09
In recent years, some investigators have found YAP to be overexpressed and highly activated in hepatic cancers and mammary cancers, suggesting its tumorigenicity. Survivin is a new member of the inhibitor of apoptotic protein family, which was initially cloned by the cDNA of the effector cell protease receptor–1 in the human genomic library in 1997.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Polymer therapeutic protects gut from radiation damage, infection after cancer treatment
EurekAlert, 12/04/09
Cigarette smoking increases colorectal cancer risk
ScienceDaily, 12/04/09
Hepatitis C drug fights virus in new way
Reuters, 12/04/09
Sponsor
Article Search
Sponsor